About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)
doi:10.1080/07315724.1999.10718845
It is used to convert homocysteine to methionine, thus supporting cardiovascular and liver health
Deficiency in essential amino acids can lead to health issues like decreased immunity, digestive problems, and mental alertness issues (7)
The evidence for KLOW is indirect : it rests on preclinical research into the individual components, not on the blend
Superior ingredients, highly absorbable formats, palatable flavors are key factors that can make a significant difference in the effectiveness of your supplement